Cogent Biosciences, Inc. (COGT)
NASDAQ: COGT · Real-Time Price · USD
8.20
0.00 (0.00%)
Jan 22, 2025, 4:00 PM EST - Market closed
Cogent Biosciences Market Cap
Cogent Biosciences has a market cap or net worth of $905.79 million as of January 22, 2025. Its market cap has increased by 84.19% in one year.
Market Cap
905.79M
Enterprise Value
583.04M
1-Year Change
84.19%
Ranking
Category
Stock Price
$8.20
Market Cap Chart
Since July 10, 2020, Cogent Biosciences's market cap has increased from $124.27M to $905.79M, an increase of 628.88%. That is a compound annual growth rate of 54.93%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 21, 2025 | 905.79M | 5.13% |
| Dec 31, 2024 | 861.60M | 70.14% |
| Dec 29, 2023 | 506.41M | -37.32% |
| Dec 30, 2022 | 807.97M | 136.30% |
| Dec 31, 2021 | 341.92M | -2.42% |
| Dec 31, 2020 | 350.40M | 181.97% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 653.46B |
| UnitedHealth Group | 469.12B |
| Johnson & Johnson | 353.99B |
| Novo Nordisk | 352.70B |
| AbbVie | 303.17B |
| Merck & Co. | 247.70B |
| Thermo Fisher Scientific | 214.07B |
| Intuitive Surgical | 211.09B |